Randomized Phase 2 Trial of Reproxalap, a Novel Reactive Aldehyde Species Inhibitor, in Patients with Noninfectious Anterior Uveitis: Model for Corticosteroid Replacement-Reference-Cited by-同舟云学术

Randomized Phase 2 Trial of Reproxalap, a Novel Reactive Aldehyde Species Inhibitor, in Patients with Noninfectious Anterior Uveitis: Model for Corticosteroid Replacement

Published:2020-12-01 Issue:10 Volume:36 Page:732-739
ISSN:1080-7683
Container-title:Journal of Ocular Pharmacology and Therapeutics
language:en
Short-container-title:Journal of Ocular Pharmacology and Therapeutics

Author:

Mandell Kenneth J.¹,Clark David¹,Chu David S.²,Foster C. Stephen³,Sheppard John⁴,Brady Todd C.¹

Affiliation:

1. Aldeyra Therapeutics, Inc., Lexington, Massachusetts, USA.

2. Metropolitan Eye Research and Surgery Institute, Palisades Park, New Jersey, USA.

3. Massachusetts Eye Research and Surgery Institution, Waltham, Massachusetts, USA.

4. Virginia Eye Consultants, Norfolk, Virginia, USA.

Publisher

Mary Ann Liebert Inc

Subject

Pharmacology (medical),Pharmacology,Ophthalmology

Link

https://www.liebertpub.com/doi/pdf/10.1089/jop.2020.0056

Reference33 articles.

1. Locally Administered Ocular Corticosteroids

2. Efficacy of the antioxidant ebselen in experimental uveitis

3. Effects of systemically applied allopurinol and prednisolone on experimental autoimmune uveitis

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Building an Understanding of Proteostasis in Reproductive Cells: The Impact of Reactive Carbonyl Species on Protein Fate ;Antioxidants & Redox Signaling;2023-12-19

2. The Phase 3 INVIGORATE Trial of Reproxalap in Patients with Seasonal Allergic Conjunctivitis;Clinical Ophthalmology;2023-12

3. Organoiridium Complexes Enhance Cellular Defense Against Reactive Aldehydes Species;Chemistry – A European Journal;2023-05-08

4. Reproxalap for the Treatment of Dry Eye Disease;US Ophthalmic Review;2023

5. Reproxalap Activity and Estimation of Clinically Relevant Thresholds for Ocular Itching and Redness in a Randomized Allergic Conjunctivitis Field Trial;Ophthalmology and Therapy;2022-05-18